Leader - Evaluation of Endotak Reliance

CompletedOBSERVATIONAL
Enrollment

904

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Ventricular TachycardiaVentricular Fibrillation
Interventions
DEVICE

Endotak Reliance

Endotak Reliance is a defibrillation lead delivering pacing and defibrillation therapy to the ventricle as needed.

Trial Locations (25)

6700

CMC Arnaud Tzanck, Saint-Laurent-du-Var

13008

CH Hôpital Nord, Marseille

13385

CHU La Timone, Marseille

14033

Hôpital Côte de Nacre, Caen

16470

Hôpital Angoulème, Angoulème

29609

CHU du Morvan, Brest

31403

CHU Rangueil, Toulouse

34295

CHU Montpellier, Montpellier

35033

CHU Pontchaillou, Rennes

37000

Clinique St. Gatien, Tours

38043

CHU Michalon, Grenoble

44000

Nouvelle Clinique Nantaise, Nantes

44295

CHU Nantes, Nantes

45000

CHU D'Orleans, Orléans

49033

CHU Angers, Angers

64046

CHG Pau, Pau

64320

Clinique Cardiologique Aressy, Aressy

76031

CHU Rouen, Rouen

80054

CH Amiens, Amiens

84902

CH Avignon, Avignon

93000

Centre cardiologique du Nord, Saint-Denis

94000

CHU Henri Mondor, Créteil

Unknown

CHU Brabois, Nancy

Clinique Bizet, Paris

06002

CHU Nice, Nice

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY